Page 7 - Tim Walbert News Today

US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.

US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune

Dublin-based global pharma company disclosed on Wednesday it was in talks about a potential sale of the company

Democratic Rep. Elissa Slotkin will stay in Congress, defeating Republican State Sen. Tom Barrett is a close race for Michigan's new 7th Congressional District.

Democratic Rep. Elissa Slotkin will stay in Congress, defeating Republican State Sen. Tom Barrett is a close race for Michigan's new 7th Congressional District.

Third-Quarter 2022 Results: -- Net Sales of $925.4 Million -- -- GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones

--Organization Will Utilize GPS and Web Services to Build a Patient-Driven Platform for the Epidermolysis Bullosa (EB) Community and Accelerate a Cure -- Horizon Therapeutics plc (Nasdaq: HZNP), in

Novel Program Supports Student Education and Future Careers in Patient Advocacy Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University

Support from Horizon Therapeutics will enable the Patient Advocacy Initiative to provide comprehensive programming that advances training, outreach and ...

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares. "This share repurchase program